Form 8-K - Current report:
SEC Accession No. 0001651308-19-000083
Filing Date
2019-08-21
Accepted
2019-08-21 16:59:13
Documents
16
Period of Report
2019-08-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kxpressrelease82119.htm   iXBRL 8-K 47200
2 EXHIBIT 99.1 ndaacceptanceen.htm EX-99.1 14410
8 ndaacceptanceenimage1.jpg GRAPHIC 193729
  Complete submission text file 0001651308-19-000083.txt   480647

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20190821.xsd EX-101.SCH 4434
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20190821_cal.xml EX-101.CAL 622
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20190821_def.xml EX-101.DEF 1472
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20190821_lab.xml EX-101.LAB 27192
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20190821_pre.xml EX-101.PRE 14088
9 EXTRACTED XBRL INSTANCE DOCUMENT a8-kxpressrelease82119_htm.xml XML 4466
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 191043548
SIC: 2834 Pharmaceutical Preparations